GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (UKEX:JNJ) » Definitions » Common Stock

Johnson & Johnson (UKEX:JNJ) Common Stock : ₴123,741 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Johnson & Johnson Common Stock?

Johnson & Johnson's quarterly common stock stayed the same from Jun. 2023 (₴123,741 Mil) to Sep. 2023 (₴123,741 Mil) and stayed the same from Sep. 2023 (₴123,741 Mil) to Dec. 2023 (₴123,741 Mil).

Johnson & Johnson's annual common stock stayed the same from Dec. 2021 (₴123,741 Mil) to Dec. 2022 (₴123,741 Mil) and stayed the same from Dec. 2022 (₴123,741 Mil) to Dec. 2023 (₴123,741 Mil).


Johnson & Johnson Common Stock Historical Data

The historical data trend for Johnson & Johnson's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Common Stock Chart

Johnson & Johnson Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 123,740.59 123,740.59 123,740.59 123,740.59 123,740.59

Johnson & Johnson Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 123,740.59 123,740.59 123,740.59 123,740.59 -

Johnson & Johnson Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Johnson & Johnson (UKEX:JNJ) Business Description

Address
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.

Johnson & Johnson (UKEX:JNJ) Headlines